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ABSTRACT
In vitro DNA amplification methods, such as poly-
merase chain reaction (PCR), rely on synthetic oli-
gonucleotide primers for initiation of the reaction.
In vivo, primers are synthesized on-template by
DNA primase. The bacteriophage T7 gene 4 protein
(gp4) has both primase and helicase activities. In
this study, we report the development of a pri-
mase-based Whole Genome Amplification (pWGA)
method, which utilizes gp4 primase to synthesize
primers, eliminating the requirement of adding
synthetic primers. Typical yield of pWGA from 1ng
to 10ng of human genomic DNA input is in the
microgram range, reaching over a thousand-fold
amplification after 1h of incubation at 378C. The
amplification bias on human genomic DNA is
6.3-fold among 20 loci on different chromosomes.
In addition to amplifying total genomic DNA, pWGA
can also be used for detection and quantification of
contaminant DNA in a sample when combined with
a fluorescent reporter dye. When circular DNA is
used as template in pWGA, 10
8-fold of amplification
is observed from as low as 100 copies of input. The
high efficiency of pWGA in amplifying circular DNA
makes it a potential tool in diagnosis and genotyp-
ing of circular human DNA viruses such as human
papillomavirus (HPV).
INTRODUCTION
Whole genome ampliﬁcation (WGA) technologies are
useful tools in many ﬁelds of studies, such as genomic
research, disease diagnostics, as well as forensic analysis.
Indeed, DNA samples used in these studies are often avail-
able in limited quantities. Amplifying the entire genome
enables researchers to perform more tests on the samples
that would otherwise be impossible. Two types of WGA
are currently being commercialized for research
applications: (1) methods derived from PCR and (2) multi-
ple displacement ampliﬁcation (MDA).
Examples of PCR-based WGA technologies include
primer extension preampliﬁcation (PEP) (1) and degener-
ate oligonucleotide primed PCR (DOP-PCR) (2), which
use random or degenerate primers, respectively, for PCR
ampliﬁcation of genomic DNA. These approaches and
other methods developed based on them (3,4) are able to
amplify DNA from a single cell (1–3,5). However, a major
problem of these PCR-based methods is incomplete cover-
age of the genome due to ampliﬁcation bias of PCR reac-
tions over certain loci (6).
Recently, an alternative method of WGA, called
OmniPlex
TM, has been developed. This method converts
randomly fragmented genomic DNA into PCR-ampliﬁ-
able units ﬂanked by universal adaptors. This library of
fragments is then ampliﬁed by PCR using universal pri-
mers (7). Compared with the aforementioned other
PCR-based WGA methods, this approach gives signiﬁ-
cantly better genome coverage and lower ampliﬁcation
bias (8). On the other hand, the length of ampliﬁcation
products from this method is rather short, ranging from
75 to 1500bp with a mean size of 400bp, and it also
requires considerably more steps in the reaction setup
(OmniPlex
TM product information, http://www.sigmaald
rich.com/sigma/bulletin/WGA1BUL.pdf).
Instead of PCR, MDA-based WGA relies on the strand
displacement activity of phage Phi29 DNA polymerase
(9). Random oligonucleotides of varying lengths, typically
hexamers (10), are used in MDA to prime DNA synthesis
by Phi29 DNA polymerase. Compared to the PCR-based
WGA methods, MDA oﬀers isothermal DNA ampliﬁca-
tion with less bias and no loss of essential sequences. It is
therefore considered the ﬁrst truly comprehensive WGA
method (11–13). Despite the advantages of the Phi29
DNA polymerase based MDA system, there are still
some limitations. The ampliﬁcation time of the system is
rather long, typically several hours (10). In addition, in
this primer-based ampliﬁcation system, an initial heat
denaturation step of the input DNA is often performed
before the isothermal ampliﬁcation to facilitate primer
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introduce mutations to the template (10) and/or contam-
inations to the reaction.
Both PCR and MDA methods require adding synthetic
oligonucleotide primers to the ampliﬁcation reactions. In
this study, we report the development of a primase-based
whole genome ampliﬁcation (pWGA) method (Figure 1),
which utilizes bacteriophage T7 gp4 primase to synthesize
primers on-template, eliminating the requirement of
adding synthetic primers. This technology is based on
the in vitro reconstitution of the naturally existing cellular
DNA replication machinery of bacteriophage T7 (15).
Bacteriophage T7 has one of the simplest DNA replica-
tion systems. Only four proteins are needed to replicate
the entire 40-kb linear genome of T7 (16). The T7 gp4 is a
bi-functional protein that serves as both a DNA helicase
and a primase. The DNA helicase activity resides at the
C-terminal half of the protein and it unwinds the duplex
DNA template using the energy generated by deoxythy-
midine triphosphate (dTTP) hydrolysis (17–19). The pri-
mase activity resides on the N-terminal half of the protein
and it recognizes nucleotide sequences 30-CTGG(G/T)-50
and 30-CTGTG-50, and generates short RNA primers for
the lagging strand synthesis (20–22). T7 DNA polymerase
holoenzyme is a heterodimer of two proteins, T7 gene 5
protein (gp5) and Escherichia coli (E. coli) thioredoxin, at
1:1 molar ratio (23–25). T7 gene 5 encodes the 50–30 DNA
polymerase and the 30–50 exonuclease (26,27). E. coli thior-
edoxin binds to T7 gp5 with an aﬃnity of 5 nM (28), and
improves the polymerase processivity (29,30). The DNA
polymerase holoenzyme is responsible for faithful and
processive DNA synthesis from the short RNA primers
generated by gp4 primase. Another protein needed for
T7 DNA replication is a single-stranded DNA (ssDNA)
binding protein encoded by T7 gene 2.5 (gp2.5). This
protein binds single-stranded DNA template (31) and
interacts with both DNA polymerase (32) and helicase/
primase (33). It has been shown that these four proteins
can generate replication products of up to 40kb through
rolling circle ampliﬁcation mode on a primed DNA tem-
plate (34,35).
In addition to the four replicative proteins described
above, three additional factors enhance the replication
eﬃciency of the pWGA system in vitro; (i) a nucleoside
diphosphokinase, (ii) an inorganic pyrophosphatase and
(iii) an ATP regeneration system consisting of creatine
kinase and phosphocreatine. As the helicase activity of
T7 gp4 uses dTTP hydrolysis to drive the unwinding of
the double stranded DNA (dsDNA) (18), it is necessary
to regenerate dTTP as the reaction progresses to avoid
bias in the ratio of the four deoxynucleoside triphosphates
(dNTPs). Nucleoside diphosphokinase transfers the g
phosphate group from nucleoside triphosphates (NTPs)
to nucleoside diphosphates (NDPs) (36), therefore equili-
brates the ratio of dNDP and dNTPs, regardless of the
base. This activity rebalances the pool of available dNTPs
for DNA synthesis. The accumulation of inorganic pyro-
phosphate during DNA synthesis is eliminated by inor-
ganic pyrophosphatase (37) in order to avoid product
inhibition of the polymerase. Finally, creatine kinase
transfers the high-energy phosphate from phosphocreatine
to dNDPs to regenerate the dNTPs consumed by nucleo-
side diphosphokinase (38), and thus help increase the
DNA yield.
The pWGA system performs fast isothermal DNA
ampliﬁcation without the need of thermocycling, prior
heat-denaturation, or added primers. In this system,
separation of DNA template strands is achieved by the
T7 DNA helicase, and initiation of DNA synthesis is
achieved by the T7 primase. Eﬃcient ampliﬁcation of tem-
plate strands is then carried out by T7 DNA polymerase
holoenzyme (Figure 1).
MATERIALS AND METHODS
Proteins
T7 gp4 helicase/primase and T7 gp2.5 ssDNA binding
protein were puriﬁed as described previously (31,39).
Native T7 DNA polymerase was purchased from New
England BioLabs, Inc (NEB) (Ipswich, MA). T7
Sequenase was purchased from USB (Cleveland, OH).
Nucleotide diphosphokinase, inorganic pyrophosphatase,
and micrococcal nuclease were purchased from Sigma
(St Louis, MO). Creatine kinase was purchased from
Roche (Basel, Switzerland).
pWGA reaction
Twenty microliters of pWGA reaction master mix was
assembled as described in (15) and it contains: 20mM
Tris–Glutamate pH 7.5, 6mM DTT, 9mM MgCl2,
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Figure 1. Mechanism of pWGA reaction.
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dNTPs, 330mM rATP, 440mM rCTP, 0.05mg/ml BSA,
3.6mg T7 gp2.5, 0.047mg native T7 DNA polymerase,
0.47mg T7 Sequenase, 0.45mg T7 gp4, 25ng nucleotide
diphosphokinase, 15ng pyrophosphatase, 750ng creatine
kinase, and 10mM creatine phosphate in a ﬁnal reaction
volume of 25ml. Two forms of the T7 DNA polymerase
were used in the pWGA master mix, the ‘native’ protein
is the wild-type T7 DNA polymerase and ‘T7 Sequenase’
is a mutant enzyme which lacks the 30–50 exonuclease
activity (40). A combination of these two forms of poly-
merases results in the most eﬃcient DNA synthesis (15).
The reaction master mix was treated with 0.05 unit of
micrococcal nuclease in the presence of 0.5mM CaCl2
at 308C for 1h to remove any DNA contamination. The
nuclease treatment was stopped by addition of EGTA to
a ﬁnal concentration of 5mM.
Ampliﬁcation was carried out simply by adding DNA
template to the master mix to reach the ﬁnal volume of
25ml and incubating the reactions at 378C for 30–120min.
The reaction was stopped by inactivation of T7 DNA
polymerase at 658C for 20min. The ampliﬁcation product
was analyzed on a 0.6% agarose gel after addition of
5 DNA agarose gel loading buﬀer containing 15%
Ficoll400, 0.3% orange G, 5mM EDTA and 0.1% SDS.
Quantification of amplification product
by PicoGreen assay
pWGA ampliﬁcation products were quantiﬁed using
Quant-iT
TM PicoGreen dsDNA kit (Invitrogen,
Carlsbad, CA), following the protocol provided by the
manufacturer. Brieﬂy, the Quant-iT
TM PicoGreen
dsDNA reagent was diluted by 20-fold in TE buﬀer
(10mM Tris–HCl, 1mM EDTA, pH 7.5). The un-ampli-
ﬁed human genomic DNA (gDNA) (Promega, Madison,
WI) was diluted to 50ng/ml in TE buﬀer. Solutions con-
taining 0, 2, 10, 20, 100, and 200ml of the diluted DNA
were added to TE buﬀer to make 1ml solutions, each con-
taining 0, 0.1, 0.5, 1, 5, and 10ng of DNA, respectively. To
these DNA solutions, 1ml of the diluted Quant-iT
TM
PicoGreen dsDNA reagent was added followed by incu-
bation at room temperature for 3min. Triplets of each
DNA solution were prepared. After incubation, sample
ﬂuorescence was measured on a SpectraMax M5 micro-
plate reader (Molecular Devices, Sunnyvale, CA) with
excitation at 480nm and emission at 520nm. The average
ﬂuorescence for each DNA sample was plotted against the
amount of DNA present in the sample and ﬁtted to a linear
equation, which served as the standard curve for quantiﬁ-
cation. Triplets of pWGA reactions were performed to
amplify from 1 or 10ng of input gDNA. The pWGA pro-
ducts were then diluted by 20-fold in TE buﬀer and 1mlo f
the diluted product was added to the cuvette for ﬂuores-
cence measurement. The average ﬂuorescent intensity was
then mapped onto the standard curve to determine the
amount of DNA present in the cuvette. pWGA product
yield was then calculated as (the amount of DNA present
in the cuvette) (20, dilution factor) (25, pWGA reac-
tion volume).
UsingpWGA amplification product as template
forDNA sequencing
One nanogram of each of the three plasmids, pTYB3
(NEB), pET28a(+), and pET15b (Novagen, Gibbstown,
NJ), was ampliﬁed by pWGA at 378C for 1h and the
reactions were stopped by heat inactivation of the enzymes
at 658C for 20min. The pWGA products were puriﬁed by
QIAquick PCR puriﬁcation kit (Qiagen, Valecia, CA) to
remove unincorporated nucleotides. A 10ml aliquot of
each puriﬁed pWGA product was used as template for
DNA sequencing by Dye-Terminator sequencing method
using AmpliTaq DNA polymerase FS on a 3130xl
Genetic analyzer (Applied Biosystems (ABI), Foster city,
CA). For each pWGA product, two separate sequencing
experiments were performed, each using a primer that is of
the opposite direction to the other. The primer sequences
for each sequencing experiment are given in Table 1.
Measurementof amplification bias byreal-time PCR
The ampliﬁcation bias of pWGA reactions was evaluated,
in comparison with MDA, by surveying the genome cov-
erage of pWGA and MDA ampliﬁcation over 20 SNP
markers across from diﬀerent chromosomes. The names
of the SNP loci are indicated on the x-axis of Figure 4.
The sequences of the primers are listed in Table S1
(Supplementary Data) and can be found in Hosono
et al. (13).
For pWGA reactions 1, 10 and 50ng of puriﬁed human
genomic DNA were ampliﬁed at 378C for 1h. Each
pWGA reaction was performed in triplets and was
stopped by incubation at 658C for 20min to inactivate
the proteins. The same amounts of gDNA were ampliﬁed
in triplets by MDA using the GenomiPhi V2 DNA ampli-
ﬁcation kit (GE Healthcare, Piscataway, NJ) at 308C for
Table 1. Using pWGA product as template for DNA sequencing
Plasmid Sequencing primer Continuous accurate sequence read
Name Length Direction Name Start Primer sequence (50–30) Start–End Length
pTYB3 7477 Forward S1248 5637 TAATACGACTCACTATAGGG 5691–6317 627
Reverse S1261 5862 ACCCATGACCTTATTACCAACCTC 5824–5100 725
pET28a(+) 5369 Forward S1271 66 TATGCTAGTTATTGCTCAG 135–799 665
Reverse S1248 386 TAATACGACTCACTATAGGG 331–1, 5369–4968 733
pET15b 5708 Forward S1271 253 TATGCTAGTTATTGCTCAG 280–897 618
Reverse S1248 479 TAATACGACTCACTATAGGG 424–1, 5708–5490 643
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tions were stopped by incubation at 658C for 10min. The
pWGA and GenomiPhi products were diluted by 25-fold
prior to use as templates for subsequent real-time PCR
assays. In these real-time PCR assays, 20 pairs of SNP
primers, each of which maps to the p or q arms of diﬀerent
chromosomes, were randomly chosen from the Whitehead
Institute-Aﬀymetrix (WIAF) human SNP database (13).
Those primers result in ampliﬁcation products ranging
from 100 to 250bp. Detection of ﬂuorescent signal in
the real-time PCR reactions was achieved by binding of
SYBR green dye to the double stranded PCR ampliﬁca-
tion product. Real-time PCR reactions were performed
using the DyNAmo
TM SYBR green qPCR kit
(Finnzymes Oy, Finland) on an ABI7300 real-time PCR
system. For each pair of primers, six reactions, each con-
taining 0, 10pg, 100pg, 1ng, 10ng or 100ng of un-ampli-
ﬁed gDNA, were performed to serve as a standard curve
for absolute quantiﬁcation. One microliter of the diluted
pWGA or GenomiPhi product was assayed for each pair
of primers by real-time PCR using the standard curve
generated for that primer set. The fold of ampliﬁcation
by pWGA or GenomiPhi for each SNP locus is calculated
as the ratio between the average amount of triplicate
pWGA or GenomiPhi reaction products and the amount
of unampliﬁed sample. Locus bias from ampliﬁcation of
a particular concentration of a sample is calculated as
the highest fold of ampliﬁcation over the lowest fold of
ampliﬁcation among the 20 loci. The yield of a pWGA or
GenomiPhi reaction is estimated from this method as the
average amount from 20 loci.
Amplification of circular DNA
The copy numbers of pCMV_GLuc (NEB) plasmid were
calculated from the concentrations provided by the suppli-
ers. Ten-fold serial dilutions in water were performed to get
desired copy numbers. For pWGA ampliﬁcation, 1ml
diluted DNA was mixed with 4ml TE and added to 20ml
of pWGA master mix. The reaction proceeded at 378C for
1h before inactivation at 658C for 20min. Ampliﬁcation
by MDA was performed using the GenomiPhi V2 DNA
ampliﬁcation kit, following the protocol from manufac-
turer. Brieﬂy, 1ml diluted DNA with 9ml sample buﬀer
was heated at 958C for 3min, chilled on ice, and then
mixed with 9ml reaction buﬀer and 1ml enzyme mix. The
reaction was incubated at 308C for 90min and inactivated
at 658C for 10min. These reaction products were then
diluted by 200-fold, 5ml of which were used as input sub-
strate for quantiﬁcation by real-time PCR using the
DyNAmo
TM SYBR green qPCR kit. The primers used
in the real-time PCR reactions are: Luc-3F (AAAGGG
CTTGCCAACGTGCAGTGTTCT) and Luc-3R (TTGA
TCTTGTCCACCTGGCCCTGGATCTT) (NEB).
Universal DNA detection
Each 25ml reaction contained 20ml of pWGA master mix,
1 ROX reference dye, 0.2 EvaGreen ﬂuorescent dye
(Biotium, Hayward, CA), and 0, 100 fg, 1pg, 10pg, 100pg
or 1ng of puriﬁed human genomic DNA. Triplicates of
reactions were assembled on ice. The reaction was carried
out on the ABI7300 real-time PCR machine at 378C
constant temperature for 120min.
RESULTS
Reaction time, amplicon lengthand product yield ofpWGA
In order to understand the capability of the pWGA
system, performance of the pWGA reactions was studied
in detail. First, the speed of pWGA in DNA ampliﬁcation
was evaluated using puriﬁed human genomic DNA as
input template. A total amount of 10ng of DNA was
added to each 25ml of pWGA reaction mix. Reactions
proceeded at a constant temperature of 378C. The reac-
tions were terminated after 0, 30, 60, 90 or 120min of
incubation, respectively, by heat inactivation of the pro-
teins at 658C for 20min. Five microliters of each of the
reactions were analyzed on a 0.6% agarose gel. Each reac-
tion was performed in triplicate. As seen from the gel
(Figure 2A), a signiﬁcant amount of ampliﬁcation product
was observed at 30min of reaction (Figure 2A, lanes 5–7).
The amount of ampliﬁcation product reached maximum
between 60 and 90min (Figure 2A, lanes 8–13).
Incubation longer than 90min did not give higher
amount of product (Figure 2A, lanes 14–16).
The products of pWGA ampliﬁcation ran as a smear on
the agarose gel, indicating the presence of branched DNA
or mixed lengths of ampliﬁcation products. The size of the
pWGA product was mostly larger than 3kb, with a sig-
niﬁcant amount larger than 10kb (Figure 2A; compare the
DNA ladder in lane 1 with the smear of pWGA products
in lanes 5–16).
The yield of pWGA reactions from 1ng or 10ng
of input human genomic DNA was quantiﬁed by measur-
ing PicoGreen ﬂuorescence (41). A standard curve was
generated with triplicates of 0.1, 0.5, 1, 5 and 10ng of
un-ampliﬁed human genomic DNA (Figure 2B, magenta
diamonds). A linear ﬁt of these data points resulted in a
slope of 22.16 units of ﬂuorescent intensity per ng of
DNA. Triplicates of pWGA products from 1ng or 10ng
input DNA were diluted by 20-fold and 1ml of the diluted
sample was added to each PicoGreen assay tube. The
ﬂuorescent intensities were measured, which corresponded
to about 6 (from 1ng input) or 10 (from 10ng input) ng of
DNA (Figure 2B, orange triangle and blue circle). Based
on the dilution factors, the total yield of pWGA product
in a 25ml reaction was about 3mg from 1ng of input and
5mg from 10ng of input [(6 or 10ng) (20, fold of
dilution) (25ml, reaction volume)], reaching up to
3000-fold of ampliﬁcation.
Using pWGA amplification product astemplate
forDNA sequencing
Three commonly used cloning plasmids, pTYB3 (NEB),
pET28a(+) and pET15b (Novagen), were ampliﬁed by
pWGA. The sizes of these plasmids range from 5.3kb
to 7.4kb (Table 1). After ampliﬁcation, the pWGA pro-
ducts were puriﬁed by QIAquick PCR puriﬁcation kit
(Qiagen) to remove unincorporated nucleotides. These
puriﬁed products were used as templates for subsequent
DNA sequencing experiments.
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experiments were performed, using primers that are of
opposite direction to each other. The commercially avail-
able sequencing primers that are widely used in cloning
experiments were chosen for this study. For the
pET28a(+) and pET15b plasmids, T7 promoter primer
(S1248, NEB) and T7 terminator primer (S1271, NEB)
were used as sequencing primers. For pTYB3, T7 promo-
ter primer and intein reverse sequencing primer (S1261,
NEB) were selected (Table 1).
The results from the sequencing experiments showed
typical patterns of sequencing peaks (Figure 3), undistin-
guishable from those using un-ampliﬁed plasmids (data
not shown). Among the six sequencing experiments, the
lengths of sequences that could be clearly read were
about 750bp (Figure 3). The lengths of sequences that
were continuous and accurate were between 618bp and
733bp (Table 1), similar to a typical sequencing results
using a plasmid as template. Sequencing experiments
using either forward or reverse primers yielded similar
results, indicating that both strands of the plasmid tem-
plate were ampliﬁed in similar ways by pWGA.
Amplification bias over20 SNP loci
To evaluate the genome coverage and ampliﬁcation bias
of pWGA reaction products, we analyzed 20 genetic mar-
kers on diﬀerent chromosomes. Namely, 20 pairs of pri-
mers that cover single nucleotide polymorphism (SNP)
loci on diﬀerent chromosomes (13) were selected and
real-time PCR reactions were performed using these pri-
mers. Using diﬀerent amounts of un-ampliﬁed human
genomic DNA as input template, a standard curve was
generated for each primer set. These standard curves
were then used to quantify the amount and thus calculate
the fold of ampliﬁcation of each locus in a pWGA pro-
duct. Triplicates of pWGA reactions were performed
using 10ng of puriﬁed human genomic DNA as input
template. To serve as a reference for comparison, the
same experiments were performed for MDA using the
GenomiPhi V2 DNA ampliﬁcation kit. The ampliﬁcation
products from pWGA and GenomiPhi were then diluted
and used as template in the following qPCR reaction. Fold
of ampliﬁcation for each locus was calculated based on the
standard curves and averaged over the three individual
pWGA or GenomiPhi experiments (Figure 4). Locus
bias from 10ng input over 20 loci for pWGA is 6.3 with
locus wiaf-966 having the highest fold of ampliﬁcation
(1099-fold) and locus wiaf-1958 having the lowest fold
of ampliﬁcation (173-fold). The average fold of ampliﬁca-
tion for pWGA over the 20 selected loci is about 400 from
10ng of input (Figure 4, magenta and red), giving a ﬁnal
yield of about 4mg, consistent with the results from
PicoGreen assays (Figure 2B). In comparison, locus
bias from 10ng input over the same 20 loci for
GenomiPhi is 2.7 with locus wiaf-1561 having the highest
fold of ampliﬁcation (432.5-fold) and locus wiaf-1331
having the lowest fold of ampliﬁcation (157.5-fold). The
average fold of ampliﬁcation for GenomiPhi over these
20 loci is about 250 (Figure 4, light blue and blue).
pWGA reactions were also performed with diﬀerent
amounts of input human genomic DNA template and
the product yield and locus bias were tested, the results
of which are listed in Table 2. Consistent with the
PicoGreen measurement, we found that pWGA product
yield was about 2mg when the input template was 1ng and
reaches about 5mg when larger amount of input was used
(Table 2). Locus bias increases when the amount of input
was limited. However, it was not greater than 11 when
only 1ng of human DNA was used as input template
for pWGA ampliﬁcation. Overall, in comparison with
the GenomiPhi V2 kit, pWGA has slightly higher ampli-
ﬁcation yield and ampliﬁcation bias.
Amplification of circular DNA
In addition to amplifying human genomic DNA, we
have examined the performance of pWGA system in
amplifying circular DNA templates. We used the 5.8kb
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Figure 2. pWGA reaction time, product length, and product yield. (A)
pWGA reactions containing 10ng human genomic DNA were termi-
nated after a speciﬁed incubation time [0 (lanes 2–4), 30 (lanes 5–7),
60 (lanes 8–10), 90 (lanes 11–13) or 120 (lanes 14–16) minutes], as
indicated at the top of the gel, and 5ml of each 25ml reaction was
analyzed on a 0.6% agarose gel. The reactions were performed in
triplicate, and lane 1 shows 500ng of 1-kb DNA ladder (NEB) with
the sizes of bands indicated on the left of the gel. The lane numbers are
indicated at the bottom of the gel. (B) Quantiﬁcation of pWGA pro-
duct yield by PicoGreen assay. Fluorescent intensity of 0.1, 0.5, 1, 5
and 10ng of un-ampliﬁed DNA (magenta diamonds) is plotted against
the amount of DNA and is ﬁtted to the linear equation shown at the
bottom right of the plot (black line) as a standard curve for quantiﬁca-
tion. Triplets of pWGA product from 1ng (orange triangle) and 10ng
(blue circle) were diluted 20 times. One microliter of the diluted pro-
ducts were assayed for PicoGreen ﬂuorescence and mapped on the
standard curve according to their intensity. The SD over three experi-
ments are shown as error bars on each data point.
PAGE 5 OF 10 Nucleic Acids Research, 2008, Vol. 36, No. 13 e79Figure 3. Representative sequencing results using the pWGA ampliﬁcation product as template. The template for sequencing was the pWGA
ampliﬁcation product from plasmid pET28a(+). The primer used for sequencing was the T7 terminator primer (S1271, NEB) that covers residues
66–84 on the plasmid and it is in the reverse direction of the plasmid. The sequencing experiment was performed by Dye-Terminator Sequencing
method using AmpliTaq DNA polymerase FS on an ABI 3130xl Genetic analyzer.
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Figure 4. Fold of pWGA and GenomiPhi ampliﬁcation over 20 SNP loci. The average fold of ampliﬁcation of 10ng input human genomic DNA for
each locus from three pWGA (magenta) or GenomiPhi (light blue) experiments is plotted with standard deviation against the primer name used to
amplify that locus. The average fold of ampliﬁcation over the 20 loci among three pWGA (red) or GenomiPh (blue) reactions is also plotted.
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pWGA reactions containing 100, 1000, 10000, 100000
and 1000000 copies of plasmid pCMV_Gluc, respectively,
were performed at 378C for 1h. In parallel, the same plas-
mids were ampliﬁed by MDA using GenomiPhi V2 DNA
ampliﬁcation kit. The products of ampliﬁcation were
quantiﬁed by real-time PCR using primers speciﬁc to
pCMV_GLuc.
We found that pWGA was able to eﬃciently amplify
the plasmid from as low as 100 copies. The yield was
1.9 10
10 copies of ampliﬁcation product from 100
copies of input (Figure 5, blue diamonds), reaching
1.9 10
8-fold of ampliﬁcation. In comparison, ampliﬁca-
tion by MDA from the same amount of input plasmid
resulted in lower yield, which was only 3.8 10
7 copies
of product DNA (Figure 5, magenta squares), reaching
3.8 10
5-fold of ampliﬁcation. Overall, in our hands, pro-
duct yield of pWGA over the range of 10
2–10
6 copies of
input plasmid was higher than that of MDA, especially
when very small amount (100–1000 copies) of DNA was
used as input template. The diﬀerence of ampliﬁcation
between pWGA and GenomiPhi from 100 copies of
input plasmid was 5 10
2-fold, and that from 1000
copies of input was 81-fold. When more plasmid (10
6
copies) was added as input template, pWGA and
GenomiPhi performed similarly in terms of fold of
ampliﬁcation.
Real-time pWGAand universal DNA detection
The ability of pWGA system to amplify DNA in real-time
was examined by performing the reaction in the presence
of SYBR green (42) or EvaGreen (43) ﬂuorescent dyes.
Real-time ﬂuorescent signal was detected within 1h of
378C reaction when 0.1 to 0.2 of either dye was pre-
sent in pWGA reaction. The ﬂuorescent signal over time
displayed a typical shape similar to that of real-time PCR
reaction (44), with an initial background phase, followed
by an exponential ampliﬁcation phase, a linear phase and
then the plateau phase (data not shown). The real-time
signal was speciﬁc for pWGA ampliﬁcation of template
DNA. If the DNA template or DNA polymerase in the
reaction was omitted, no real-time signal was detected
(data not shown).
Furthermore, real-time pWGA reactions were
performed with diﬀerent amount of input template. Tripli-
cates of reactions containing 100 fg, 1pg, 10pg, 100pg and
1ng of puriﬁed human genomic DNA were carried out at
378C on an ABI7300 real-time PCR machine (Figure 6A).
The real-time pWGA signal indicates that detection of
1ng of input DNA took less than 10min. Detection of as
low as 100 fg of DNA was consistently observed at around
1h of incubation (Figure 6A) and was signiﬁcantly distin-
guished from background non-speciﬁc ampliﬁcation,
which occurred in only one of the triplets after 90min of
incubation (Figure 6A, NTC). The cycle numbers at which
the ﬂuorescent signal crossed the threshold (Ct) are plotted
against the amount of input template and ﬁtted to a linear
Table 2. Locus bias of pWGA and GenomiPhi from diﬀerent amounts
of input DNA template
Amount of
input DNA (ng)
11 0 5 0
pWGA MDA pWGA MDA pWGA MDA
Fold of ampliﬁcation
a 1829 2084 399 254.9 93 54.7
SD
a 188 49 79.8 21.5 25 8.4
Product yield (mg) 1.8 2.1 4.0 2.5 4.6 2.7
Locus bias 10.9 3.2 6.3 2.7 4.9 2.4
aFold of ampliﬁcation and SD are the average from triplicates of
pWGA reactions.
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Figure 5. Ampliﬁcation of circular DNA. Various amounts of pCMV_GLuc plasmid were used as substrates for side-by-side pWGA (blue diamonds)
and MDA reactions (magenta squares). The copy numbers of ampliﬁed plasmids DNA were determined by comparing with standard curves
generated from templates of known copy numbers through real-time PCR using primers Luc-3F and Luc-3R.
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(R
2=0.98) over 4 orders of magnitude of input template,
from 100 fg to 1ng, indicating an exponential ampliﬁcation
of the input template by pWGA over this range of input.
The time it took for the product to increase 10 times was
13min (Figure 6B, slope).
DISCUSSION
Suﬃcient quantity of genomic DNA is crucial in many
aspects of genomic research, clinical diagnostics, and for-
ensic studies. The DNA source often becomes a limiting
factor in these studies. A method that can amplify a mini-
mal amount of DNA from diﬀerent sources to large quan-
tity without signiﬁcant loss of genome coverage is
instrumental. In this study, we describe a new method of
rapid, isothermal, whole genome ampliﬁcation technol-
ogy, pWGA. This method is based on the naturally exist-
ing bacteriophage T7 DNA replication system, in which
the duplex template is separated by T7 DNA helicase.
Single-stranded DNA is protected by T7 ssDNA-binding
protein. Ampliﬁcation is dependent on T7 primase to
generate short primers for extension by DNA polymerase.
These four proteins are suﬃcient to amplify the 40-kb T7
linear genome in vivo (16). When puriﬁed and assembled
in vitro, together with the accessory proteins to re-generate
and re-balance nucleotide substrates, we have shown that
the T7 DNA replication proteins can amplify a small
amount of input human genomic DNA (1ng) to reach
microgram quantity.
One of the advantages of the pWGA system is that it is
truly isothermal. No thermal cycling is needed and heat
denaturation of the template prior to ampliﬁcation is not
necessary in pWGA. The reaction is started and proceeds
by incubation of the template with the reaction master
mix at 378C. The true isothermal nature of the system
simpliﬁes the reaction setup. In addition, it eliminates
the exposure of template DNA to high temperature,
thus reducing the chance of introducing unwanted muta-
tions. Another advantage of the pWGA system is the reac-
tion speed: microgram quantity of ampliﬁcation product
from as low as 1ng of input DNA can be obtained within
1h of incubation. The fast reaction speed, together with
the simple isothermal reaction scheme, makes the system
potentially useful in a point of care diagnostic setting
where fast results are needed and laboratory instruments
are limited.
pWGA reaction product is suitable for a variety of
downstream assays. After a simple clean up step to
remove excess nucleotides and proteins, pWGA product
can be used for DNA sequencing (Figure 3). pWGA pro-
ducts can also be used directly as template for PCR reac-
tions without puriﬁcation. The T7 DNA polymerase in
pWGA system eﬃciently incorporates modiﬁed nucleo-
tides such as biotin-dNTP and the labeled products can
then be applied to microarrays for genomic studies (data
not shown).
Faithful representation of the input template is an
essential requirement for any kind of WGA technology.
The product quality of pWGA was evaluated by agarose
gel electrophoresis and by surveying the genome coverage
and ampliﬁcation bias using real-time PCR. The high
molecular weight product of pWGA observed on the gel
is a close representation of the input template and is a
desirable feature in assays such as enzymatic digestion,
cloning and DNA sequencing. Ampliﬁcation bias is a
severe problem in PCR-based WGA technologies due to
the possibility of uneven annealing of primers to the tem-
plate. Instead of using added primers, the primase based
WGA technology utilizes a primase to synthesize primers.
The ability of the system to synthesis primers eliminates
the primer annealing preference and could potentially
reduce ampliﬁcation bias. In this study, we surveyed 20
genetic markers on diﬀerent chromosomes for the cover-
age and ampliﬁcation bias of pWGA. We showed that
from 10ng of input DNA, all the 20 loci were ampliﬁed
by pWGA by 173–1099-fold. There was no loss of the
genome coverage among the 20 loci and the bias was
less than 7-fold when input DNA was more than 10ng.
Even from as low as 1ng of input (about 300 copies of the
genome), the bias was only 11-fold. The ampliﬁcation bias
of our pWGA system is similar to that of MDA (Figure 4
and Table 2) and is much lower than those of PCR-based
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Figure 6. Real-time quantitative pWGA. (A) Real-time ampliﬁcation
signal (Delta Rn) from triplets of 0 (NTC), 100 fg, 1pg, 10pg,
100pg and 1ng of input DNA is plotted against reaction time. The
threshold is drawn as a green line. (B) Ct number from diﬀerent
amount of input template is plotted against the amount of input
template with a linear ﬁt shown as a green line. The slope and the
goodness of ﬁt (R
2-value) are shown at the top right of the plot. The
template amount on the x-axis is distributed on a log scale.
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product is used in subsequent genome researches, such
as comparative genomic hybridization (CGH), where
genome copy number changes are investigated (45).
The ability of pWGA to eﬃciently amplify circular
DNA enables the use of this system in detecting and sub-
sequently identifying and genotyping DNA virus samples.
The other usage of circular DNA ampliﬁcation is to
restore an archived DNA specimen, which is often frag-
mented and poses a problem for direct WGA ampliﬁca-
tion. Recently, Wang et al. described a strategy to recover
archived DNA by restriction and circularization-aided
rolling circle ampliﬁcation (RCA-RCA) (46). In this strat-
egy, fragmented DNA is circularized ﬁrst and then ampli-
ﬁed by rolling circle ampliﬁcation. The pWGA system is
particularly suited for use in this method because of its
high eﬃciency in amplifying circular DNA.
The pWGA system can be used to quantitatively detect
trace amount of DNA in a universal real-time assay with-
out the need of adding target-speciﬁc primers. The pWGA
assay can be used to detect and quantify residual DNA
level in a given biological sample or in a pharmaceutical
product. The detection sensitivity is 100fg of DNA and
the dynamic range for quantiﬁcation is 10
4, from 100fg to
1ng. The reaction is very fast and detection of 100fg of
DNA occurs in only one hour. This fast and sensitive
WGA-based universal DNA detection assay can be per-
formed in a general laboratory setting using a real-time
PCR machine. This is the ﬁrst report of the use of WGA
technology as a molecular tool for detecting trace amounts
of contaminant DNA.
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